Compare DexCom, Inc. (DXCM) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Sprott Uranium Miners ETF — how do they compare? DexCom, Inc. trades at $76.89 (market cap $28.06B), while Sprott Uranium Miners ETF trades at $48.86. The key difference: DexCom, Inc. is trading nearer its 52-week high, Sprott Uranium Miners ETF nearer its low. Which is the better fit depends on your goals.
| DXCM | URNM | |
|---|---|---|
Market Cap | $28.06B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $89.53 | $83.99 |
52-Week Low | $54.84 | $44.14 |
Enterprise Value | $27.03B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
URNM (Sprott Uranium Miners ETF) trades at $49.49, down 4.07% today amid bearish technical signals with all 15 moving averages indicating sell signals. The ETF provides concentrated exposure to uranium miners, benefiting from the nuclear energy revival driven by AI power demand. Recent news highlights uranium's strategic role in meeting data center electricity needs, though the sector experienced recent volatility with uranium stocks declining.
The uranium sector faces a decade-long supply-demand imbalance favoring miners, though URNM's pure-miner focus brings higher volatility. Key risks include uranium price fluctuations and miner operational challenges. Analyst sentiment is mixed with some seeing long-term opportunity while others caution about stretched valuations relative to underlying uranium prices.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
